CD274 and neoplasm: The study identified that Coprobacillus cateniformis and Erysipelatoclostridium ramosum enhanced the efficacy of anti-PD-L1 immunotherapy by downregulating PD-L2 expression on dendritic cells in lymph nodes, a crucial role in promoting anti-tumor immunity.